[
    [
        {
            "time": "",
            "orginal_text": "再谈创新药指数指数投资价值分析",
            "features": {
                "keywords": [
                    "创新药",
                    "指数",
                    "投资价值"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "再谈创新药指数指数投资价值分析",
            "scores": {
                "News_content": "再谈创新药指数指数投资价值分析",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "副业超主业，“基层市场器械之王”乐普拆分医药上市，但主业地盘就被攻进来",
            "features": {
                "keywords": [
                    "乐普",
                    "拆分",
                    "医药",
                    "上市",
                    "主业",
                    "器械"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "器械"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "副业超主业，“基层市场器械之王”乐普拆分医药上市，但主业地盘就被攻进来",
            "scores": {
                "News_content": "副业超主业，“基层市场器械之王”乐普拆分医药上市，但主业地盘就被攻进来",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "场外资金坐不住了：医疗器械板块不是业绩超预期就是股价创新高",
            "features": {
                "keywords": [
                    "场外资金",
                    "医疗器械",
                    "业绩",
                    "股价",
                    "创新高"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "场外资金坐不住了：医疗器械板块不是业绩超预期就是股价创新高",
            "scores": {
                "News_content": "场外资金坐不住了：医疗器械板块不是业绩超预期就是股价创新高",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "新股前瞻丨押注热门靶点，乐普生物能否借PD-1出圈？",
            "features": {
                "keywords": [
                    "新股",
                    "乐普生物",
                    "PD-1",
                    "热门靶点"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "新股前瞻丨押注热门靶点，乐普生物能否借PD-1出圈？",
            "scores": {
                "News_content": "新股前瞻丨押注热门靶点，乐普生物能否借PD-1出圈？",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "2021年，这些药企更受资本青睐！",
            "features": {
                "keywords": [
                    "2021年",
                    "药企",
                    "资本",
                    "青睐"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "2021年，这些药企更受资本青睐！",
            "scores": {
                "News_content": "2021年，这些药企更受资本青睐！",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "orginal_text": "A股收盘：创业板指为何逆势涨超1%？生物医药股霸占大半周线前十成分股",
            "features": {
                "keywords": [
                    "A股",
                    "收盘",
                    "创业板指",
                    "生物医药",
                    "逆势上涨"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "A股收盘：创业板指为何逆势涨超1%？生物医药股霸占大半周线前十成分股",
            "scores": {
                "News_content": "A股收盘：创业板指为何逆势涨超1%？生物医药股霸占大半周线前十成分股",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "北上资金加仓多只绩优疫苗股，9股增持超亿",
            "features": {
                "keywords": [
                    "北上资金",
                    "加仓",
                    "疫苗",
                    "绩优股"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "北上资金加仓多只绩优疫苗股，9股增持超亿",
            "scores": {
                "News_content": "北上资金加仓多只绩优疫苗股，9股增持超亿",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "海外疫情持续！Q1业绩向好资金加仓疫苗及新冠检测等股大涨",
            "features": {
                "keywords": [
                    "海外疫情",
                    "Q1业绩",
                    "疫苗",
                    "新冠检测",
                    "资金加仓"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "疫苗",
                    "检测"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "海外疫情持续！Q1业绩向好资金加仓疫苗及新冠检测等股大涨",
            "scores": {
                "News_content": "海外疫情持续！Q1业绩向好资金加仓疫苗及新冠检测等股大涨",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "械“小阳春”渐入佳境，市场首只医疗器械ETF上市迎“开门红”",
            "features": {
                "keywords": [
                    "医疗器械",
                    "ETF",
                    "小阳春",
                    "开门红"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "械“小阳春”渐入佳境，市场首只医疗器械ETF上市迎“开门红”",
            "scores": {
                "News_content": "械“小阳春”渐入佳境，市场首只医疗器械ETF上市迎“开门红”",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "乐普医疗拆分公司乐普生物港交所递表",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "拆分",
                    "乐普生物",
                    "港交所",
                    "递表"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "乐普医疗拆分公司乐普生物港交所递表",
            "scores": {
                "News_content": "乐普医疗拆分公司乐普生物港交所递表",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "千亿白酒股直线跌停！郭广昌又笑了，发生了什么",
            "features": {
                "keywords": [
                    "白酒",
                    "跌停",
                    "郭广昌"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "千亿白酒股直线跌停！郭广昌又笑了，发生了什么",
            "scores": {
                "News_content": "千亿白酒股直线跌停！郭广昌又笑了，发生了什么",
                "Correlation": 2,
                "Sentiment": 3,
                "Importance": 5,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "乐普医疗：集采影响逐步消退期待创新器械产品",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "集采",
                    "创新器械",
                    "影响消退"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "乐普医疗：集采影响逐步消退期待创新器械产品",
            "scores": {
                "News_content": "乐普医疗：集采影响逐步消退期待创新器械产品",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]